Trimodality treatment in Stage III nonsmall cell lung carcinoma: prrognostic impact of K-ras mutations after neoadjuvant therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/11932909

Cancer 2002 Apr 1 94 7 2055-62

Download in:

View as

General Info

PMID
11932909